29731

    506879

    GUJTHEM

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    GUJARAT THEMIS BIOSYN LTD Share Price Today

    GUJARAT THEMIS BIOSYN LTD is currently trading at ₹375.1, up by ₹0.55 from the previous close. The stock touched an intraday high of ₹378.00 and a low of ₹373.00 during the latest trading session. Over the past one year, GUJARAT THEMIS BIOSYN LTD has delivered a return of 9.33%, while the stock has declined 6.14% in the last one month.

    GUJARAT THEMIS BIOSYN LTD performance

    Today’s low Today’s high
    ₹ 373.00 ₹ 378.00
    ₹ 371.00
    52 week low 52 week high
    ₹ 225.05 ₹ 479.00
    ₹ 371.00
    Open Price ₹ 377.20
    Prev. Close ₹ 374.55
    Volume (Shares) 22044.00
    Total traded value ₹ 81.78
    Upper Circuit ₹ 449.45
    Lower Circuit ₹ 299.65
    info

    Investment Returns

    Over 1 Month -6.14% Over 3 Months 43.36% Over 6 Months -11.08% Over 1 Year 9.33%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    GUJARAT THEMIS BIOSYN LTD fundamentals


    • Market cap (Cr) 4,042.60
    • P/E Ratio (TTM) 85.51
    • Beta 1.78
    • Book Value / share 26.40
    • Return on equity 21.69%
    • EPS (TTM) 4.28
    • Dividend yield 0.18%
    • Net profit/quarter (Cr) 10.89
    info icon alternate text
    • Market cap (Cr) 4,060.60
    • P/E Ratio (TTM) 85.51
    • Beta 1.59
    • Book Value / share 26.40
    • Return on equity 21.69%
    • EPS (TTM) 4.28
    • Dividend yield 0.18%
    • Net profit/quarter (Cr) 10.89
    info icon alternate text

    GUJARAT THEMIS BIOSYN LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 44.23
    Operating Expense 30.82
    Net Profit 10.89
    Net Profit Margin (%) 24.62
    Earnings Per Share (EPS) 1.00
    EBITDA 20.29
    Effective Tax Rate (%) 24.05
    Particulars DEC 2025 (Values in Cr)
    Revenue 43.37
    Operating Expense 26.91
    Net Profit 12.46
    Net Profit Margin (%) 28.72
    Earnings Per Share (EPS) 1.14
    EBITDA 21.72
    Effective Tax Rate (%) 26.14
    Particulars SEP 2025 (Values in Cr)
    Revenue 42.35
    Operating Expense 24.40
    Net Profit 14.26
    Net Profit Margin (%) 33.67
    Earnings Per Share (EPS) 1.31
    EBITDA 21.76
    Effective Tax Rate (%) 23.98
    Particulars JUN 2025 (Values in Cr)
    Revenue 35.87
    Operating Expense 24.02
    Net Profit 9.06
    Net Profit Margin (%) 25.25
    Earnings Per Share (EPS) 0.83
    EBITDA 14.18
    Effective Tax Rate (%) 25.24
    Particulars MAR 2025 (Values in Cr)
    Revenue 37.74
    Operating Expense 23.00
    Net Profit 12.00
    Net Profit Margin (%) 31.79
    Earnings Per Share (EPS) 1.10
    EBITDA 17.39
    Effective Tax Rate (%) 25.41
    Particulars MAR 2026 (Values in Cr)
    Revenue 165.82
    Operating Expense 106.16
    Net Profit 46.68
    Net Profit Margin (%) 28.15
    Earnings Per Share (EPS) 4.28
    EBITDA 77.96
    Effective Tax Rate (%) 24.81
    Particulars MAR 2025 (Values in Cr)
    Revenue 150.80
    Operating Expense 87.69
    Net Profit 48.77
    Net Profit Margin (%) 32.34
    Earnings Per Share (EPS) 4.48
    EBITDA 71.27
    Effective Tax Rate (%) 25.58
    Particulars MAR 2024 (Values in Cr)
    Revenue 169.82
    Operating Expense 94.85
    Net Profit 59.16
    Net Profit Margin (%) 34.83
    Earnings Per Share (EPS) 8.14
    EBITDA 83.10
    Effective Tax Rate (%) 25.42
    Particulars MAR 2023 (Values in Cr)
    Revenue 148.39
    Operating Expense 77.51
    Net Profit 57.97
    Net Profit Margin (%) 39.06
    Earnings Per Share (EPS) 39.90
    EBITDA 80.22
    Effective Tax Rate (%) 25.17
    Particulars MAR 2022 (Values in Cr)
    Revenue 114.85
    Operating Expense 59.87
    Net Profit 43.62
    Net Profit Margin (%) 37.97
    Earnings Per Share (EPS) 30.03
    EBITDA 62.08
    Effective Tax Rate (%) 26.10
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 22.79
    ROE % 21.69
    ROCE % 27.21
    Total Debt to Total Equity 0.07
    EBITDA Margin 47.26
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 27.72
    ROE % 33.76
    ROCE % 44.82
    Total Debt to Total Equity 0.01
    EBITDA Margin 48.93
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 102.66
    ROE % 45.92
    ROCE % 60.85
    Total Debt to Total Equity 0.01
    EBITDA Margin 54.06
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 71.11
    ROE % 50.35
    ROCE % 66.38
    Total Debt to Total Equity 0.03
    EBITDA Margin 54.07
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 48.14
    ROE % 53.83
    ROCE % 66.39
    Total Debt to Total Equity 0.12
    EBITDA Margin 48.13
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 12.54
    Total Assets 301.31
    Total Liabilities 301.31
    Total Equity 248.38
    Share Outstanding 10
    Price to Book Ratio 12.35
    Return on Assets (%) 16.18
    Return on Capital (%) 17.53
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 8.15
    Total Assets 221.11
    Total Liabilities 221.11
    Total Equity 201.37
    Share Outstanding 7
    Price to Book Ratio 14.29
    Return on Assets (%) 26.75
    Return on Capital (%) 29.38
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 9.33
    Total Assets 166.32
    Total Liabilities 166.32
    Total Equity 149.14
    Share Outstanding 1
    Price to Book Ratio 6.69
    Return on Assets (%) 34.85
    Return on Capital (%) 38.87
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 12.34
    Total Assets 122.50
    Total Liabilities 122.50
    Total Equity 103.32
    Share Outstanding 1
    Price to Book Ratio 5.73
    Return on Assets (%) 35.61
    Return on Capital (%) 42.22
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 27.63
    Total Assets 88.26
    Total Liabilities 88.26
    Total Equity 69.94
    Share Outstanding 1
    Price to Book Ratio 4.23
    Return on Assets (%) 34.19
    Return on Capital (%) 41.36
    Particulars MAR 2025 (Values in Cr)
    Net Income 65.53
    Cash from Operations 107.51
    Cash from Investing -111.81
    Cash from Financing 26.01
    Net change in Cash 5.22
    Free Cash Flow 223.66
    Particulars MAR 2024 (Values in Cr)
    Net Income 79.33
    Cash from Operations 83.99
    Cash from Investing -55.21
    Cash from Financing -8.58
    Net change in Cash 0.41
    Free Cash Flow 158.63
    Particulars MAR 2023 (Values in Cr)
    Net Income 77.46
    Cash from Operations 59.89
    Cash from Investing -20.40
    Cash from Financing -13.27
    Net change in Cash 5.79
    Free Cash Flow 83.60
    Particulars MAR 2022 (Values in Cr)
    Net Income 59.03
    Cash from Operations 54.82
    Cash from Investing -29.83
    Cash from Financing -13.99
    Net change in Cash -3.51
    Free Cash Flow 68.72
    Particulars MAR 2021 (Values in Cr)
    Net Income 40.88
    Cash from Operations 20.65
    Cash from Investing -2.25
    Cash from Financing -5.16
    Net change in Cash 3.11
    Free Cash Flow 23.71
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 13.24 1.55 245.46 23.12 38.85
    BLISS GVS PHARMA LTD 511.55 41.12 4.54 5425.31 118.35 552.90
    CIPLA LTD. 1452.35 30.82 3.40 117327.41 1165.55 1672.20
    FERMENTA BIOTECH LTD. 369.50 16.30 2.67 1087.47 256.40 401.20
    GLAXOSMITHKLINE PHARMA LT 2402.90 42.30 17.95 40706.58 2088.00 3356.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 22.40 4.12 245.46 23.12 38.85
    AMRUTAJAN HEALTH LTD 538.95 24.16 4.20 1558.14 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8200.05 107.09 23.48 20500.13 7630.00 9850.00
    BLISS GVS PHARMA LTD 511.55 55.30 4.69 5425.31 118.35 552.90

    GUJARAT THEMIS BIOSYN LTD shareholding pattern

    Holding
    26.16%
    70.86%
    1.79%
    1.17%
    5.44%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    GUJARAT THEMIS BIOSYN LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    371.00 1.25 redarrow
    red-green-graph indicator
    13 Bearish
    3 Bullish
    • 5 Days 385.50
    • 26 Days 386.90
    • 10 Days 388.30
    • 50 Days 376.20
    • 12 Days 388.70
    • 100 Days 364.30
    • 20 Days 388.50
    • 200 Days 346.30
    380.50 PIVOT
    First Support 372.55 First Resistance 385.20 Second Support 367.85 Second Resistance 393.15 Third Support 359.90 Third Resistance 397.85
    RSI 45.28 ADX 8.83 MACD 1.75 Williams % R -82.58 Commodity Channel Index (CCI) -90.70
    Date 2026-07-07 Week 47945.00 Same Day 23923.00 Month 82866.00
    1 Year 1.78 3 Year -4.28
    Over 1 Month
    -6.14% down
    Over 1 Year
    9.33% down
    Over 3 Months
    43.36% down
    Over 3 Years
    0.00% down
    Over 6 Months
    -11.08% down
    Over 5 Years
    0.00% down

    GUJARAT THEMIS BIOSYN LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    04 Sep 2025 0.67 Final 05 Sep 2025 Equity shares
    15 Jul 2024 0.25 Final 16 Jul 2024 Equity shares
    22 Feb 2024 0.75 Interim 22 Feb 2024 Equity shares
    01 Sep 2023 1.0 Final 02 Sep 2023 Equity shares
    01 Dec 2022 4.4 Interim 02 Dec 2022 Equity shares
    29 Aug 2022 4.0 Final 31 Aug 2022 Equity shares
    24 Nov 2021 5.0 Special 25 Nov 2021 Equity shares
    24 Nov 2021 2.0 Interim 25 Nov 2021 Equity shares
    10 Sep 2020 1.65 Final 14 Sep 2020 Equity shares
    Ex-Date Ex-Bonus Ratio
    09 Aug 2024 09 Aug 2024 1:2
    Ex-Date Old FV NEW FV Record Date
    10 Oct 2023 5.0 1.0 10 Oct 2023
    Dividend date Dividend amount Dividend type Record date Instrument type
    04 Sep 2025 0.67 Final 05 Sep 2025 Equity shares
    15 Jul 2024 0.25 Final 16 Jul 2024 Equity shares
    22 Feb 2024 0.75 Interim 22 Feb 2024 Equity shares
    01 Sep 2023 1.0 Final 02 Sep 2023 Equity shares
    01 Dec 2022 4.4 Interim 02 Dec 2022 Equity shares
    29 Aug 2022 4.0 Final 31 Aug 2022 Equity shares
    24 Nov 2021 5.0 Special 25 Nov 2021 Equity shares
    24 Nov 2021 2.0 Interim 25 Nov 2021 Equity shares
    10 Sep 2020 1.65 Final 14 Sep 2020 Equity shares
    Ex-Date Ex-Bonus Ratio
    09 Aug 2024 09 Aug 2024 1:2
    Ex-Date Old FV NEW FV Record Date
    10 Oct 2023 5.0 1.0 10 Oct 2023

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Gujarat Themis Biosyn Ltd?

    Answer Field

    Gujarat Themis Biosyn Ltd share price is for NSE ₹ 375.10 & for BSE ₹ 376.00 as on Jul 10 2026 10:18 AM.

    What is the Market Cap of Gujarat Themis Biosyn Ltd Share?

    Answer Field

    The market cap of Gujarat Themis Biosyn Ltd for NSE ₹ 4,042.60 & for BSE ₹ 0.00 as on Jul 10 2026 10:18 AM.

    What is the 52 Week High and Low of Gujarat Themis Biosyn Ltd?

    Answer Field

    The 52 Week High and Low of Gujarat Themis Biosyn Ltd for NSE is ₹ 479.00 and ₹ 225.05 and for BSE is ₹ 479.45 and ₹ 225.75.

    What is 1 year return for Gujarat Themis Biosyn Ltd?

    Answer Field

    The 1 year returns on the stock has been 5.24%.

    What is the P/E Ratio of Gujarat Themis Biosyn Ltd Share?

    Answer Field

    As on Jul 10 2026 10:18 AM the price-to-earnings (PE) ratio for Gujarat Themis Biosyn Ltd share is 85.51.

    What is the PB ratio of Gujarat Themis Biosyn Ltd Share?

    Answer Field

    As on Jul 10 2026 10:18 AM, the price-to-book (PB) ratio for Gujarat Themis Biosyn Ltd share is 26.40.

    How to Buy Gujarat Themis Biosyn Ltd Share?

    Answer Field

    You can trade in Gujarat Themis Biosyn Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Gujarat Themis Biosyn Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Gujarat Themis Biosyn Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Gujarat Themis Biosyn Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |